Merck Other Operating Income or Expenses 2010-2024 | MKKGY
Merck annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- Merck other operating income or expenses for the quarter ending June 30, 2024 were $-0.335B, a 181.79% increase year-over-year.
- Merck other operating income or expenses for the twelve months ending June 30, 2024 were $-0.535B, a 35.12% decline year-over-year.
- Merck annual other operating income or expenses for 2023 were $-0.472B, a 35.09% decline from 2022.
- Merck annual other operating income or expenses for 2022 were $-0.727B, a 199.74% increase from 2021.
- Merck annual other operating income or expenses for 2021 were $-0.243B, a 584.92% increase from 2020.
Merck Annual Other Operating Income or Expenses
(Millions of US $) |
| 2023 |
$-472 |
| 2022 |
$-727 |
| 2021 |
$-243 |
| 2020 |
$-35 |
| 2019 |
$-31 |
| 2018 |
$-149 |
| 2017 |
$328 |
| 2016 |
$17 |
| 2015 |
$-496 |
| 2014 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Other Operating Income or Expenses
(Millions of US $) |
| 2024-06-30 |
$-335 |
| 2024-03-31 |
$-85 |
| 2023-12-31 |
$-83 |
| 2023-09-30 |
$-33 |
| 2023-06-30 |
$-119 |
| 2023-03-31 |
$-237 |
| 2022-12-31 |
$-237 |
| 2022-09-30 |
$-233 |
| 2022-06-30 |
$-170 |
| 2022-03-31 |
$-88 |
| 2021-12-31 |
$-94 |
| 2021-09-30 |
$-35 |
| 2021-06-30 |
$-98 |
| 2021-03-31 |
$-16 |
| 2020-12-31 |
$-122 |
| 2020-09-30 |
$348 |
| 2020-06-30 |
$-182 |
| 2020-03-31 |
$-81 |
| 2019-12-31 |
$18 |
| 2019-09-30 |
$-46 |
| 2019-06-30 |
$91 |
| 2019-03-31 |
$-94 |
| 2018-12-31 |
$62 |
| 2018-09-30 |
$-64 |
| 2018-06-30 |
$-142 |
| 2018-03-31 |
$-5 |
| 2017-12-31 |
$-280 |
| 2017-09-30 |
$437 |
| 2017-06-30 |
$69 |
| 2017-03-31 |
$101 |
| 2016-12-31 |
$-97 |
| 2016-09-30 |
$-57 |
| 2016-06-30 |
$-134 |
| 2016-03-31 |
$304 |
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
